| Dr Elizabeth Anne Heskett Bouressa, MD | |
|
734 Elm St Sw, Albany, OR 97321-1934 | |
| (541) 812-5111 | |
| Not Available |
| Full Name | Dr Elizabeth Anne Heskett Bouressa |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 734 Elm St Sw, Albany, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104890631 | NPI | - | NPPES |
| 082623 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD203466 (Oregon) | Primary |
| Entity Name | Lane County Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326138314 PECOS PAC ID: 7416853833 Enrollment ID: O20040309000023 |
News Archive
DARA BioSciences, Inc., announces the positive results from a successfully completed Phase 1b clinical study for DB959, its peroxisome proliferator activated receptor (PPAR)-delta/gamma agonist, a non-TZD oral drug in development for the treatment of type 2 diabetes.
An experimental drug aimed at restoring the immune system's ability to spot and attack cancer halted cancer progression or shrank tumors in patients with advanced melanoma, according to a multisite, early-phase clinical trial at Johns Hopkins Kimmel Cancer Center and 11 other institutions. All patients had experienced disease progression despite prior systemic therapies, and most had received two or more prior treatments.
The Leapfrog Group announced its list of Top Hospitals at its Annual Meeting today, highlighting the diversity of hospitals represented nationwide. Widely cited as the nation's most competitive hospital quality award, the Top Hospitals designation recognizes hospitals that deliver the highest quality care by preventing medical errors, reducing mortality for high-risk procedures like heart bypass surgery, and reducing readmissions for patients being treated for conditions like pneumonia and heart attack.
Center for Human Identification at the University of North Texas Health Science Center (UNTHSC) analyzes DNA from unidentified human remains for law enforcement organizations and medical examiners across the country in an attempt to put a name to a body or victim. The result, in many cases, is resolution for family members who have spent years wondering about the fate of their loved one.
› Verified 6 days ago
| Entity Name | Albany General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154372340 PECOS PAC ID: 9931097987 Enrollment ID: O20040310000310 |
News Archive
DARA BioSciences, Inc., announces the positive results from a successfully completed Phase 1b clinical study for DB959, its peroxisome proliferator activated receptor (PPAR)-delta/gamma agonist, a non-TZD oral drug in development for the treatment of type 2 diabetes.
An experimental drug aimed at restoring the immune system's ability to spot and attack cancer halted cancer progression or shrank tumors in patients with advanced melanoma, according to a multisite, early-phase clinical trial at Johns Hopkins Kimmel Cancer Center and 11 other institutions. All patients had experienced disease progression despite prior systemic therapies, and most had received two or more prior treatments.
The Leapfrog Group announced its list of Top Hospitals at its Annual Meeting today, highlighting the diversity of hospitals represented nationwide. Widely cited as the nation's most competitive hospital quality award, the Top Hospitals designation recognizes hospitals that deliver the highest quality care by preventing medical errors, reducing mortality for high-risk procedures like heart bypass surgery, and reducing readmissions for patients being treated for conditions like pneumonia and heart attack.
Center for Human Identification at the University of North Texas Health Science Center (UNTHSC) analyzes DNA from unidentified human remains for law enforcement organizations and medical examiners across the country in an attempt to put a name to a body or victim. The result, in many cases, is resolution for family members who have spent years wondering about the fate of their loved one.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elizabeth Anne Heskett Bouressa, MD Po Box 1189, Corvallis, OR 97339-1189 Ph: () - | Dr Elizabeth Anne Heskett Bouressa, MD 734 Elm St Sw, Albany, OR 97321-1934 Ph: (541) 812-5111 |
News Archive
DARA BioSciences, Inc., announces the positive results from a successfully completed Phase 1b clinical study for DB959, its peroxisome proliferator activated receptor (PPAR)-delta/gamma agonist, a non-TZD oral drug in development for the treatment of type 2 diabetes.
An experimental drug aimed at restoring the immune system's ability to spot and attack cancer halted cancer progression or shrank tumors in patients with advanced melanoma, according to a multisite, early-phase clinical trial at Johns Hopkins Kimmel Cancer Center and 11 other institutions. All patients had experienced disease progression despite prior systemic therapies, and most had received two or more prior treatments.
The Leapfrog Group announced its list of Top Hospitals at its Annual Meeting today, highlighting the diversity of hospitals represented nationwide. Widely cited as the nation's most competitive hospital quality award, the Top Hospitals designation recognizes hospitals that deliver the highest quality care by preventing medical errors, reducing mortality for high-risk procedures like heart bypass surgery, and reducing readmissions for patients being treated for conditions like pneumonia and heart attack.
Center for Human Identification at the University of North Texas Health Science Center (UNTHSC) analyzes DNA from unidentified human remains for law enforcement organizations and medical examiners across the country in an attempt to put a name to a body or victim. The result, in many cases, is resolution for family members who have spent years wondering about the fate of their loved one.
› Verified 6 days ago
Adam B Paul, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 734 Elm St Sw, Albany, OR 97321 Phone: 541-812-5111 Fax: 541-812-5127 | |
Dr. Christina M. Miller, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1123 Hill St Se Ste B, Albany, OR 97322 Phone: 541-207-7431 Fax: 541-644-5071 | |
Dr. Letrice Blair, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 734 Elm St Sw, Albany, OR 97321 Phone: 541-812-5111 | |
Dr. Neda Afzali, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 734 Elm St Sw, Albany, OR 97321 Phone: 541-812-5111 Fax: 541-812-5127 | |
Dr. Lisa A. Boyd, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 734 Elm St Sw, Albany, OR 97321 Phone: 541-812-5111 Fax: 541-926-9360 | |
Dr. Matthew D. Zollinger, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 400 Nw Hickory Street, Suite 300, Albany, OR 97321 Phone: 541-812-5700 |